AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPhenomena and ProcessesDisciplines and OccupationsInformation Science
von Willebrand Factorvon Willebrand DiseasesRistocetinPlatelet Glycoprotein GPIb-IX ComplexFactor VIIICollagenPlatelet AdhesivenessBlood Coagulation FactorsBlood Plateletsvon Willebrand Disease, Type 2Weibel-Palade BodiesPlatelet Membrane Glycoproteinsvon Willebrand Disease, Type 1Platelet AggregationDeamino Arginine VasopressinADAM ProteinsBleeding TimeCrotalid VenomsHemostasisFibrinogenPurpura, Thrombotic ThrombocytopenicCollagen Type IPlatelet ActivationEndothelium, Vascularvon Willebrand Disease, Type 3Bernard-Soulier SyndromeThrombosisThrombinReceptors, CollagenProtein BindingBlood Coagulation TestsHemophilia AMolecular Sequence DataStress, MechanicalBlood CoagulationP-SelectinMetalloendopeptidasesUmbilical VeinsEndotheliumRecombinant ProteinsBlood Platelet DisordersAmino Acid SequenceCells, CulturedAntibodies, MonoclonalMacromolecular SubstancesHemorheologyFibrillar CollagensThrombomodulinBiological MarkersAurintricarboxylic AcidPeptide FragmentsEndothelial CellsAfibrinogenemiaBinding SitesThrombospondinsPlatelet Glycoprotein GPIIb-IIIa ComplexCollagen Type IVCollagen Type VICollagen Type IIIProtein Structure, TertiaryCell AdhesionHemostaticsAntigensMolecular WeightElectrophoresis, Polyacrylamide GelBase SequenceGlycoproteinsExtracellular MatrixImmunoelectrophoresis, Two-DimensionalCoagulation Protein DisordersHemorrhagic DisordersPlatelet CountFibrin Fibrinogen Degradation ProductsFibronectinsElectrophoresis, Agar GelHemorrhageABO Blood-Group SystemPlatelet Function TestsCollagen Type IIIntegrin alpha2Galactose OxidaseKineticsMutationCytoplasmic GranulesDisulfidesProtein MultimerizationThrombotic MicroangiopathiesMegakaryocytesEnzyme-Linked Immunosorbent AssayExtracellular Matrix ProteinsBlood Viscosityvon Hippel-Lindau DiseasePartial Thromboplastin TimePoint MutationProtein ConformationProtein PrecursorsTime FactorsFibrinolysisBlood Coagulation DisordersCricetinae
GlycoproteinFibrinogenPlateletsFibronectinExtracellularAdhesionAggregationProteinsBindsEpinephrineThrombinVIIIP2Y12AntigenGPVIGPIbPeptideType 2MIIIaMolecularProteinMultimer analysisBindAgonistFibrinAssaysInhibitorsDefectEndothelial activationMoleculesCoagulation factor deficienciesDisordersAbundantDeterminationActivationAntibodyPrimarilyVascularHemophiliaDense granules containDefectsLipoproteinTissueInducePatientsDeficiencyPDGFActivates factorPlasminogenCofactor
Glycoprotein16
  • ii) Determination of the platelet receptor glycoprotein Ib extracellular domain and von Willebrand factor A1 domain structures (iii) determination of the coagulation factor xi structure. (nottingham.ac.uk)
  • The process of thrombus formation is considered to be initiated by von Willebrand factor (VWF) binding to exposed collagen or laminin in the damaged vessel wall, followed by shear-dependent platelet binding to VWF through the glycoprotein (GP)Ib-V-IX complex ( 1 , 3 , 4 ). (frontiersin.org)
  • The flow-dependent adhesion of platelets to those and other extracellular matrix components is stabilized by a panel of integrins, including integrin α 2 β 1 , α IIb β 3 , and α 6 β 1 (adhesive platelet population), while the initial activation of platelets is achieved by signaling via the collagen/laminin receptor, glycoprotein VI (GPVI). (frontiersin.org)
  • Collagen receptors include discoidin domain receptors, INTEGRINS, and glycoprotein VI. (lookformedical.com)
  • von Willebrand factor (vWF) is a large multimeric glycoprotein synthesized as a 2050 amino acid monomer in endothelium, megakaryocytes, and the subendothelial connective tissue. (medscape.com)
  • V ON WILLEBRAND FACTOR (vWF) is a multimeric glycoprotein (GP) that plays a key role, under high-shear conditions, in the initial attachment of platelets to the extracellular matrix of the endothelial cells after injury of the vessel wall. (ashpublications.org)
  • Examples include the glycoprotein IIb-IIIa receptor, which is targeted by antiplatelets such as tirafiban. (teachmephysiology.com)
  • When a platelet binds to collagen, the glycoprotein IIb/IIIa pathway is activated - a complex system controlled by G-protein coupled receptors (GPCRs). (teachmephysiology.com)
  • Platelets play a primary role in this process, interacting with subendothelium-bound von Willebrand factor (vWf) via the membrane glycoprotein (GP) Ib complex. (medscape.com)
  • BACKGROUND: The von Willebrand factor (VWF) is a multimeric plasma glycoprotein essential for hemostasis, inflammation, and angiogenesis. (imperial.ac.uk)
  • In conclusion, EMP-PDI promotes early platelet activation through glycoprotein (GP) IIb/IIIa receptors present on platelet surface in the diabetic state. (aging-us.com)
  • However, the ultimate common pathway of platelet aggregation is the activation of glycoprotein (GP) IIb/IIIa receptors present on platelet surface [ 7 - 9 ]. (aging-us.com)
  • Platelet adhesion (ie, of platelets to exposed vascular subendothelium) requires von Willebrand factor (VWF) and the platelet glycoprotein Ib/IX complex. (msdmanuals.com)
  • Storage-stable glycoprotein blood coagulation factor that can be activated to factor Xa by both the intrinsic and extrinsic pathways. (lookformedical.com)
  • FACTOR VII is a Vitamin K dependent glycoprotein essential to the extrinsic pathway of coagulation. (lookformedical.com)
  • In the 1970s, the molecular defect was shown to involve the absence of a platelet membrane glycoprotein (GPIb/IX/V) complex which is the receptor for von Willebrand factor (vWF). (medscape.com)
Fibrinogen14
Platelets23
  • The interaction with collagen leads to stabilization of the platelets. (wikipedia.org)
  • The activities of adhesion and signaling receptors in platelets are controlled by several mechanisms. (frontiersin.org)
  • The proteases involved are of different origins and types: (i) present as precursor in plasma, (ii) secreted into the plasma by activated platelets or other blood cells, or (iii) intracellularly activated and cleaving cytosolic receptor domains. (frontiersin.org)
  • Phosphatidylserine-exposing platelets, usually located around a thrombus, provide a negatively charged membrane surface, which supports coagulation factor binding and the formation of tenase and prothrombinase complexes ( 6 , 7 ). (frontiersin.org)
  • Although these platelet activation processes are relatively well-studied as a function of the platelet environment, only since recently it is becoming clear that a multitude of proteases present in plasma or produced by platelets themselves are important for the distinct properties of platelet populations, often by cleaving specific receptors. (frontiersin.org)
  • A history of prolonged bleeding, a prolonged bleeding time, and failure of platelets to aggregate in response to L-epinephrine, adenosine 5'-diphosphate (ADP), collagen, and arachidonic acid are diagnostic of thrombasthenia. (medscape.com)
  • Platelets are activated when brought into contact with collagen (which is exposed when the endothelial blood vessel lining is damaged), thrombin (primarily through PAR -1), ADP receptors (P2Y1 and P2Y12) expressed on platelets, a negatively charged surface (e.g. glass), or several other activating factors. (wikidoc.org)
  • The platelets adhere to each other via adhesion receptors or integrins , and to the endothelial cells in the wall of the blood vessel forming a haemostatic plug in conjunction with fibrin . (wikidoc.org)
  • Important in the maintenance of hemostasis, it promotes adhesion of platelets to the sites of vascular injury by forming a molecular bridge between sub-endothelial collagen matrix and platelet-surface receptor complex GPIb-IX-V. Also acts as a chaperone for coagulation factor VIII, delivering it to the site of injury, stabilizing its heterodimeric structure and protecting it from premature clearance from plasma. (rcsb.org)
  • Bitiscetin has recently been shown to induce von Willebrand factor (vWF)-dependent aggregation of fixed platelets (Hamako J, et al, Biochem Biophys Res Commun 226:273, 1996). (ashpublications.org)
  • The localization of the binding site of bitiscetin within the A3 domain was further supported by showing that MoAb to vWF, which are specific for this domain and block the interaction between vWF and collagen, are potent inhibitors of the binding of bitiscetin to vWF and consequently of the bitiscetin-induced binding of vWF to platelets. (ashpublications.org)
  • Platelets have abundant surface receptors , classified into agonist and adhesion receptors. (teachmephysiology.com)
  • Adhesion receptors promote the adhesion of platelets to other platelets, the vessel wall or leucocytes , depending on the receptor stimulated. (teachmephysiology.com)
  • Exposed collagen fibres bind vWF released from the damaged endothelium, which in turn binds to vWF receptors on platelets to promote adhesion. (teachmephysiology.com)
  • 1) Immune mediated damage near infected endothelial cells leads to collagen exposure, fibrin deposition, platelet activation, endothelial activation, and release of ultra-high molecular weight vWF from endothelial cells and platelets. (cdc.gov)
  • The hemostatic system consists of platelets, coagulation factors, and the endothelial cells lining the blood vessels. (medscape.com)
  • Under physiological circumstances, the resistance of the endothelial cell lining to interactions with platelets and coagulation factors prevents thrombosis. (medscape.com)
  • This initial interaction (platelet adhesion) sets the stage for other adhesive reactions that allow the platelets to interact with other agonists in the vicinity of vessel injury, such as adenosine 5'-diphosphate (ADP), subendothelial collagen, and thrombin. (medscape.com)
  • Platelets were activated with ADP, thrombin, or the thrombin receptor agonist peptide SFLLRN (TRAP 1-6 ). (nature.com)
  • Recent and extensive in vitro and in vivo studies have supported the promising and unique capability of APAC to produce a local antithrombotic effect by contextually inhibiting the collagen-induced aggregation and the deposition of activated platelets and reducing the fibrin formation at the site of vascular injury. (lww.com)
  • Overview of Hemostasis Hemostasis, the arrest of bleeding from an injured blood vessel, requires the combined activity of Vascular factors Platelets Plasma coagulation factors Regulatory mechanisms counterbalance. (msdmanuals.com)
  • The released ADP acts on the P2Y12 receptor on other platelets, thereby activating them and recruiting them to the site of injury. (msdmanuals.com)
  • Platelet aggregation tests assess the ability of platelets to clump in response to the addition of various activators (eg, collagen, epinephrine , ADP, ristocetin). (msdmanuals.com)
Fibronectin4
Extracellular6
  • Collagen receptors are cell surface receptors that modulate signal transduction between cells and the EXTRACELLULAR MATRIX. (lookformedical.com)
  • A non-fibrillar collagen that forms a network of MICROFIBRILS within the EXTRACELLULAR MATRIX of CONNECTIVE TISSUE. (lookformedical.com)
  • This classification was based on the notion that "collagen" was equivalent to "connective tissue", but with the present recognition of the different types of collagen and the aggregates derived from them as distinct entities, the term "collagen diseases" now pertains exclusively to those inherited conditions in which the primary defect is at the gene level and affects collagen biosynthesis, post-translational modification, or extracellular processing directly. (lookformedical.com)
  • Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. (lookformedical.com)
  • Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes. (9dok.net)
  • CD51, an ~120 kDa surface molecule can also non-covalently associate with other beta subunits of the integrin family including beta1 (CD29), beta5 and beta6 to form receptors for extracellular matrix components. (thermofisher.com)
Adhesion4
Aggregation7
  • The collagen-induced platelet aggregation of platelet-rich plasma samples from 14 healthy rabbits was measured turbidometrically using a platelet aggregometer, before and 1 hour after intravenous injection of alum. (who.int)
  • Collagen-induced platelet aggregation was significantly reduced after alum injection. (who.int)
  • contradiction in the mechanism of action of alum, we evaluated the in vivo effect of Alum (aluminium potassium sulfate) is a alum in terms of collagen-induced platelet food additive and traditional remedy used to aggregation and bleeding time. (who.int)
  • Platelet aggregation is stimulated by thromboxane and α2 receptor -activation, but inhibited by other inflammatory products like PGI2 and PGD2 . (wikidoc.org)
  • They are found in many cell types and are involved in the maintenance and regulation of cell shape and behavior, including PLATELET ACTIVATION and aggregation, through many different signaling pathways and differences in their affinities for collagen isoforms. (lookformedical.com)
  • 3 Among the platelet dysfunction, the commonest disorder is decreased aggregation response to ristocetin, in the presence of normal VWF:RCo and VWF(von willebrand factor). (org.pk)
  • Platelet function tests showed a decreased response to adenosine diphosphate (ADP), collagen, ristocetin and epinephrine - induced aggregation. (org.pk)
Proteins4
  • Every monomer contains particular binding domains that provide them the capacity to interact and bind other proteins specifically, factor VIII, collagen, and some platelet receptors. (medscape.com)
  • Induced EndoMT cells exhibited up-regulation of mesenchymal markers, including collagen type I and α-smooth muscle actin, and a reduction in endothelial cell and junctional proteins, including von Willebrand factor, CD31, occludin, and vascular endothelial-cadherin. (surrey.ac.uk)
  • Among the range of proteins shown to co-localize to WPB is angiopoietin-2 (Angpt-2), a ligand of the receptor tyrosine kinase Tie-2. (imperial.ac.uk)
  • Contrary to reef building corals, the red coral organic matrix possesses a large number of collagen-like proteins. (biomedcentral.com)
Binds2
  • von Willebrand factor (vWF) binds the exposed collagen and binds GP Ib-IX-V complex on the surface of the platelet. (medscape.com)
  • vWF also binds circulating factor VIII and prevents it peripheral degradation. (medscape.com)
Epinephrine1
Thrombin5
VIII10
P2Y122
  • Data from a radiolabeled ligand‑binding assay indicated that LGP exhibited apparent competing effects on thromboxane receptor (TP) and P2Y12 receptors. (spandidos-publications.com)
  • These inhibitory effects may be associated with its dual‑receptor inhibition on P2Y12 and TP receptors. (spandidos-publications.com)
Antigen1
  • Her von Willebrand antigen (VWF: Ag), VWF- ristocetin co-factor (VWF: RCo) were within normal limits. (org.pk)
GPVI1
GPIb3
  • The binding of von Willebrand factor (vWF) results in conformational changes within the GPIb-V-IX complex. (wikipedia.org)
  • In this mechanism, vWF acts as a molecular bridge between constituents of the subendothelium, like collagen, and receptors of the platelet membrane, primarily the GPIb. (ashpublications.org)
  • VWF protects FVIII from degradation and transports it to plasma, and mediates platelet activation by binding to their membrane receptors GPIb and GPIIb / IIIa. (cryopep.com)
Peptide1
  • The C-terminal end of the alpha1 chain of collagen type XVIII contains the ENDOSTATIN peptide, which can be released by proteolytic cleavage. (lookformedical.com)
Type 2M2
  • a decrease in the rate of VWF (type 1 and type 3) - an absence of HPM multimer (type 2A and 2B) : a rare specific deficiency in collagen binding is classified as type 2M. (cryopep.com)
  • The elusive and heterogeneous pattern of type 2M von Willebrand disease: A diagnostic challenge. (cdc.gov)
IIIa5
  • Approximately 80,000 GP IIb-IIIa receptors are present on the surface of each platelet. (medscape.com)
  • Qin R , Zhu H , Wang F , Song M , Lin P , Xing Y , Zhang W , Zhong M , Wang Z , . Platelet activation in diabetic mice models: the role of vascular endothelial cell-derived protein disulfide isomerase-mediated GP IIb/IIIa receptor activation. (aging-us.com)
  • GP IIb/IIIa receptor activation plays an important role in thrombosis. (aging-us.com)
  • The mechanism of early activation of GP IIb/IIIa receptors in diabetic conditions remains unknown. (aging-us.com)
  • This process relies on the destruction of disulfide bonds present on these receptors, such as Cys5-Cys435, Cys663-Cys687, and a third Cys-rich repetitive zone, to be transformed into the ligand-binding, high-affinity state and evoke conformational changes in GP IIb/IIIa receptors [ 10 ]. (aging-us.com)
Molecular5
  • The findings show how a crucial enzyme in our blood, known as ADAMTS13, works like a pair of molecular scissors to carefully cut back the clotting effects of a key protein, von Willebrand factor (VWF). (nottingham.ac.uk)
  • The high molecular weight forms of VWF preferentially bind to collagen than the low molecular weight forms. (cryopep.com)
  • In parallel 503 CD34+ cells have been plated in CFU-MK colony assays in collagen-based media (Megacult-C #04901) in chamber slides in the presence of 1-10 M MK-2206 or DMSO (0.1 ) and scored immediately after 14 days by Nav1.4 Molecular Weight staining with an anti-CD41 antibody. (5htreceptor.com)
  • Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF. (cdc.gov)
  • Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients. (cdc.gov)
Protein4
  • Von Willebrand issue (VWF) is a 500- to 15 000-kDa multimeric protein circulating within the blood. (holliseden.com)
  • 2003): Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. (9dok.net)
  • Heat- and storage-stable plasma protein that is activated by tissue thromboplastin to form factor VIIa in the extrinsic pathway of blood coagulation. (lookformedical.com)
  • Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients. (cdc.gov)
Multimer analysis1
  • The plasma von Willebrand factor (vWF) multimer analysis provides a qualitative visual assessment of the size spectrum and the banding pattern of VWF multimers present in plasma compared with a normal control. (medscape.com)
Bind1
  • Allows the identification of samples with a proven deficit of VWF multimers using a polyclonal antibody and the ability of VWF to bind to type VI collagen. (cryopep.com)
Agonist1
Fibrin2
Assays1
Inhibitors4
  • The use of novel B-cell receptor signaling inhibitors results in high response rates and long progression-free survival in patients with indolent B-cell malignancies, such as chronic lymphocytic leukemia, follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinemia. (haematologica.org)
  • In this review we discuss the most commonly reported and/or most clinically relevant adverse events associated with these B-cell receptor inhibitors, with special emphasis on recommendations for their management. (haematologica.org)
  • Richter transformation is not discussed extensively as it is not an adverse event, although it is important to be aware that Richter transformation is occasionally observed during treatment with B-cell receptor inhibitors. (haematologica.org)
  • In addition, acquired disorders such as coagulation factor inhibitors affect adults more often than children. (medscape.com)
Defect1
  • A hereditary deficiency of blood coagulation factor XI (also known as plasma thromboplastin antecedent or PTA or antihemophilic factor C) resulting in a systemic blood-clotting defect called hemophilia C or Rosenthal's syndrome, that may resemble classical hemophilia. (lookformedical.com)
Endothelial activation1
  • Cardiovascular (CV) risk factors such as hypercholesterolemia, hyperglycaemia, obesity, hypertension, smoking, and aging promote vascular inflammation and endothelial activation [ 7 - 9 ]. (hindawi.com)
Molecules2
  • Collagen type IV molecules assemble to form a sheet-like network which is involved in maintaining the structural integrity of basement membranes. (lookformedical.com)
  • The identification of the key molecules that accurately regulate the activation of these receptors may provide a novel approach for antiplatelet therapy. (aging-us.com)
Coagulation factor deficiencies2
  • Platelet disorders lead to defects in primary hemostasis and produce signs and symptoms different from coagulation factor deficiencies (disorders of secondary hemostasis). (medscape.com)
  • The common conditions associated with menorrhagia include von Willebrand disease (VWD), platelet function disorders and coagulation factor deficiencies. (org.pk)
Disorders2
  • Functional platelet disorders are generally associated with immediate bleeding in response to surgery or trauma, whereas factor deficiencies are associated with delayed bleeding. (arupconsult.com)
  • This includes milder phenotypes of congenital disorders such as hemophilia and von Willebrand disease (VWD). (medscape.com)
Abundant1
  • A fibrillar collagen consisting of three identical alpha1(III) chains that is widely distributed in many tissues containing COLLAGEN TYPE I. It is particularly abundant in BLOOD VESSELS and may play a role in tissues with elastic characteristics. (lookformedical.com)
Determination4
Activation4
  • Bruton's tyrosine kinase (BTK) is a downstream component of the B-cell receptor (BCR) involved in normal differentiation, survival and proliferation of peripheral B cells as well as participation in platelet activation signaling pathways [1-3]. (fortuneonline.org)
  • Bom,V.J. and Bertina,R.M. (1990): The contributions of Ca 2+ , phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII. (9dok.net)
  • In thrombosis, platelet activation serves as the initiation factor. (aging-us.com)
  • The activated form then catalyzes the activation of factor X to factor Xa. (lookformedical.com)
Antibody3
Primarily1
Vascular3
  • A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. (lookformedical.com)
  • The atherosclerotic process is accelerated by a myriad of factors, such as the release of inflammatory chemokines and cytokines, the generation of reactive oxygen species (ROS), growth factors, and the proliferation of vascular smooth muscle cells. (hindawi.com)
  • Controlling these factors reduces the risk of acute vascular complications and death from CVD [ 1 , 7 ]. (hindawi.com)
Hemophilia2
Dense granules contain1
  • The dense granules contain proaggregatory factors such as ADP, calcium, and 5-hydroxytryptamine (serotonin). (medscape.com)
Defects1
  • Because mucocutaneous bleeding can result from a variety of defects or from an illness such as von Willebrand disease (VWD) , a number of possibilities must be considered during initial patient evaluation. (arupconsult.com)
Lipoprotein1
  • Oxidation of low-density lipoprotein (LDL) cholesterol is one of the key factors for the development of atherosclerosis. (hindawi.com)
Tissue4
  • A family of structurally related collagens that form the characteristic collagen fibril bundles seen in CONNECTIVE TISSUE. (lookformedical.com)
  • After 2 weeks, the tissue was harvested and subjected to Masson trichrome staining, and collagen I and III and alpha-smooth muscle actin detection by immunohistochemistry. (bvsalud.org)
  • The maintenance of tissue homeostasis and proper wound healing is, therefore, a critical process that can be disturbed by a plethora of external and internal factors. (biomedcentral.com)
  • Description: A sandwich quantitative ELISA assay kit for detection of Rat Insulin Receptor (ISR) in samples from serum, plasma, tissue homogenates or other biological fluids. (tuberculosistest.net)
Induce2
  • DMFs induce collagen I and III expressions in rat paws compared with NHDFs, with a type III to I ratio increase. (bvsalud.org)
  • CONCLUSIONS: Treating DMFs with PRP+ASCs provides factors that induce myofibroblast to adipocyte transformation. (bvsalud.org)
Patients5
  • Ces résultats semblent indiquer que l'utilisation de l'alun en tant qu'antiplaquettaire oral pourrait faire l'objet d'études complémentaires, en tenant compte des effets secondaires éventuels notamment chez les patients dont la fonction rénale est altérée. (who.int)
  • Histologic assessment of patients with systemic sclerosis-associated PAH and the hypoxia/SU5416 mouse model identified the presence von Willebrand factor/α-smooth muscle actin-positive endothelial cells in up to 5% of pulmonary vessels. (surrey.ac.uk)
  • Consistent with this, a number of studies have shown that patients with severe COVID-19 have highly elevated plasma levels of von Willebrand Factor (VWF) that may contribute to the prothrombotic phenotype. (imperial.ac.uk)
  • Genetic variation in the C-type lectin receptor CLEC4M in type 1 von Willebrand Disease patients. (cdc.gov)
  • Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients. (cdc.gov)
Deficiency2
  • A deficiency of factor X, sometimes called Stuart-Prower factor deficiency, may lead to a systemic coagulation disorder. (lookformedical.com)
  • The absence of prekallikrein in plasma leads to Fletcher factor deficiency, a congenital disease. (lookformedical.com)
PDGF1
  • It also secretes e.g. platelet-derived growth factor (PDGF). (wikidoc.org)
Activates factor2
Plasminogen1
  • Produced in the liver, plasminogen is activated to form plasmin by factors XIa and XIIa. (teachmephysiology.com)
Cofactor1